Curevac reports progress in intellectual property infringement case against biontech in germany

Regional court dÜsseldorf postpones infringement ruling on four intellectual property rights in lawsuit filed by curevac against biontech ruling on infringement to be provided latest once the validity of the intellectual property rights in suit has been determined by the relevant patent offices expected in 2024 as german infringement courts only suspend the proceedings if an intellectual property right is infringed and its validity has been challenged, it may be concluded that the regional court dÜsseldorf found all four intellectual property rights to be infringed ruling on infringement of a fifth intellectual property right scheduled for december 28, 2023 tÜbingen, germany and boston, ma / accesswire / september 28, 2023 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced that the regional court dÜsseldorf has decided to suspend proceedings on four intellectual property rights in the infringement lawsuit filed by curevac against biontech.
CVAC Ratings Summary
CVAC Quant Ranking